Chui-Ze Kong (Chuize Kong)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Renal Cell Carcinoma

Cell Proliferation

Top Venues

Journal of cellular and molecular medicine

Cancer gene therapy

The world journal of men's health

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhongru Fan, Peng Xin, Lin Zhao, Chui-Ze Kong, Chiyuan Piao, Zhengqi Wu, Zhongkai Qiu, Wei Zhao, Zhe Zhang
Ferroptosis Is Crucial for Cisplatin Induced Sertoli Cell Injury via N6-Methyladenosine Dependent Manner. The world journal of men's health (2024)
Zhuonan Liu, Tianshui Sun, Chiyuan Piao, Zhe Zhang, Chui-Ze Kong
METTL14-mediated N 6 -methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma. Cell communication and signaling : CCS 20 (1) (2022)
Xiaotong Zhang, Jiarun Zhang, Wei Zhao, Xiao Dong, Peng Xin, Xi Liu, Xuejie Li, Zhifei Jing, Zhe Zhang, Chui-Ze Kong, Xiuyue Yu
Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway. Cancer gene therapy 28 (12) (2021)
Xiaotong Zhang, Jiarun Zhang, Hao Zhang, Yang Liu, Lei Yin, Xi Liu, Xuejie Li, Xiuyue Yu, Jinlong Yao, Zhe Zhang, Chui-Ze Kong
Exploring the five different genes associated with PKCα in bladder cancer based on gene expression microarray. Journal of cellular and molecular medicine 25 (3) (2021)
Zhuonan Liu, Tianshui Sun, Chiyuan Piao, Zhe Zhang, Chui-Ze Kong
METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. Journal of translational medicine 19 (1) (2021)
Bo Zhan, Zhe Zhang, Chiyuan Piao, Xiao Dong, Yang Du, Chui-Ze Kong, Yuanjun Jiang
The Sigma-2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K-AKT-mTOR Signalling Pathway in Renal Cancer. Journal of cellular and molecular medicine 25 (24) (2021)
Yexiang Huang, Yuyan Zhu, Zhe Zhang, Zhenhua Li, Chui-Ze Kong
Correction: UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53. Cancer gene therapy (2021)
Hongyuan Yu, Junlong Liu, Zhe Zhang, Yuyan Zhu, Jianbin Bi, Chui-Ze Kong
SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p. Journal of cellular and molecular medicine 25 (10) (2021)
Yexiang Huang, Yuyan Zhu, Zhe Zhang, Zhenhua Li, Chui-Ze Kong
UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53. Cancer gene therapy 27 (12) (2020)
Yang Du, Chui-Ze Kong
STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma. Cancer gene therapy 28 (5) (2020)
Yexiang Huang, Zhe Zhang, Miao Miao, Chui-Ze Kong
The intracellular domain of UNC5B facilities proliferation and metastasis of bladder cancer cells. Journal of cellular and molecular medicine 25 (4) (2020)
Zhi-Fei Jing, Jian-Bin Bi, Zeliang Li, Xiankui Liu, Jun Li, Yuyan Zhu, Xiao-Tong Zhang, Zhe Zhang, Zhenhua Li, Chui-Ze Kong
Inhibition of miR-34a-5p can rescue disruption of the p53-DAPK axis to suppress progression of clear cell renal cell carcinoma. Molecular oncology 13 (10) (2019)
Xi Liu, Xiaotong Zhang, Jianbin Bi, Zhenhua Li, Zhe Zhang, Chui-Ze Kong
Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells. Journal of cellular and molecular medicine 23 (12) (2019)
Chiyuan Piao, Xiaolu Cui, Bo Zhan, Jun Li, Zeliang Li, Zhenhua Li, Xiankui Liu, Jianbin Bi, Zhe Zhang, Chui-Ze Kong
Inhibition of stearoyl CoA desaturase-1 activity suppresses tumour progression and improves prognosis in human bladder cancer. Journal of cellular and molecular medicine 23 (3) (2018)